Physician

Chawki Gerges, M.D.

According to 2025 Medicare claims, Chawki Gerges, M.D. (NPI: 1982600946) practices internal medicine in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is CHAWKI GERGES MD INC (NPI: 1710923529; TIN: 204371961) and primary practice location at 93291-5166.

Gerges' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,294 traditional Medicare patients, billed 14,822 HCPCS/CPT codes, and received $608,978 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 33,250 prescription claims across 1,264 beneficiaries totaling $1,644,157 in drug costs, led by Eliquis (Apixaban). DME data shows 1,510 claims. Open Payments data shows 33 records totaling $630. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $929,930 to $608,978. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $64,087 and ending at $74,289.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,893	13,622	$929,930
2016	1,871	13,752	$999,546
2017	1,986	16,690	$1,109,227
2018	1,786	15,102	$887,928
2019	1,690	17,893	$790,669
2020	2,170	14,162	$719,264
2021	1,816	13,495	$737,322
2022	1,336	16,356	$634,887
2023	1,268	23,376	$702,017
2024	1,294	14,822	$608,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,215	27,140	$1,588,336
2016	1,260	28,421	$1,517,624
2017	1,363	30,085	$1,615,887
2018	1,360	32,876	$1,816,011
2019	1,276	33,839	$1,742,651
2020	1,185	28,406	$1,593,418
2021	1,199	26,906	$1,495,258
2022	1,235	27,438	$1,583,510
2023	1,226	30,055	$1,735,790
2024	1,264	33,250	$1,644,157

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	668	2,166	$78,824
2016	655	2,079	$76,774
2017	504	2,077	$84,714
2018	574	2,111	$113,929
2019	577	2,054	$100,109
2020	551	1,872	$69,658
2021	402	1,356	$41,740
2022	481	1,384	$51,012
2023	425	1,561	$67,426
2024	418	1,510	$75,228

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	191	194	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	817	3,215	$88
99497	Advance care planning, first 30 minutes	158	188	$63
90661	Influenza vaccine, trivalent derived from cell cultures	270	271	$36
G0008	Administration of influenza virus vaccine	273	280	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	467	11,495	$225,822
Farxiga	Dapagliflozin Propanediol	226	8,410	$154,072
Ozempic	Semaglutide	128	4,516	$139,107
Jardiance	Empagliflozin	199	5,453	$104,443
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	105	4,902	$103,078

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	32	$19,134
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	25	177	$11,091
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	17	$6,549
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	35	78	$3,484
A7032	Cushion for use on nasal mask interface, replacement only, each	N	18	40	$3,399

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$630	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chawki Gerges, M.D.?

Tedicare shows public-source Medicare data for Chawki Gerges, M.D. (NPI 1982600946), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chawki Gerges, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chawki Gerges, M.D.?

Chawki Gerges, M.D. is linked to CHAWKI GERGES MD INC (billing NPI 1710923529) in the available physician profile data.

Does Chawki Gerges, M.D. have Open Payments data?

Chawki Gerges, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.